Showing results 1 to 20 of 23
next >
| Rights | Preview | Issue Date | Title | Author(s) | Type |
| openAccess |  | 2013 | Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials | Bringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio | artículo |
| closedAccess |  | 2014 | Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy | Mateos, Maria Victoria; Bringhen, Sara; Richardson, Paul G.; Lahuerta, Juan José; García-Sanz, Ramón; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio | artículo |
| closedAccess |  | 2014 | Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study | Morabito, Fortunato; Bringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio | artículo |
| closedAccess |  | 2016 | Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma | Donk, Niels W. C. J. van de; Moreau, Philippe; Plesner, Torben; Palumbo, Antonio; Gay, Francesca; Laubach, Jacob P.; Malavasi, Fabio; Avet-Loiseau, Hervé; Mateos, Maria Victoria; Sonneveld, Pieter; Lokhorst, Henk M.; Richardson, Paul G. | artículo |
| closedAccess |  | 2012 | European perspective on multiple myeloma treatment strategies: Update following recent congresses | Ludwig, Heinz; Bladé, Joan; Cavo, Michele; Moreau, Philippe; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio | artículo |
| openAccess |  | 2014 | Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma | Dimopoulos, Meletios A.; Palumbo, Antonio; Moreau, Philippe; Delforge, Michel; Cavo, Michele; Ludwig, Heinz; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 14-Mar-2019 | High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma | Thakurta, Anjan; Ortiz, María; Blecua, Pedro; Towfic, Fadi; Corre, Jill; Serbina, Natalya V.; Flynt, Erin; Yu, Zhinuan; Yang, Zhihong; Palumbo, Antonio; Dimopoulos, Meletios A.; Gutiérrez, Norma Carmen; Goldschmidt, Hartmut; Sonneveld, Pieter; Avet-Loiseau, Hervé | artículo |
| closedAccess |  | 2012 | How to manage neutropenia in multiple myeloma | Palumbo, Antonio; Bladé, Joan; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2014 | Initial treatment of transplant-ineligible patients in multiple myeloma | Mateos, Maria Victoria; Leleu, Xavier; Palumbo, Antonio; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2009 | International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation | Palumbo, Antonio; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2020 | Ixazomib as postinduction maintenance for patients with newly diagnosed multiple myeloma not undergoing autologous stem cell transplantation: The phase III TOURMALINE-MM4 trial | Dimopoulos, Meletios A.; Špička, Ivan; Quach, Hang; Oriol, Albert; Hajek, Roman; Garg, Mamta; Beksac, Meral; Bringhen, Sara; Katodritou, Eirini; Chng, Wee-Joo; Leleu, Xavier; Iida, Shinsuke; Mateos, Maria Victoria; Morgan, Gareth J.; Vorog, Alexander; Labotka, Richard; Wang, Bingxia; Palumbo, Antonio; Lonial, Sagar | artículo |
| openAccess |  | 2021 | Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life | Terpos, Evangelos; Mikhael, Joseph; Hajek, Roman; Chari, Ajai; Zweegman, Sonja; Lee, Hans C.; Mateos, Maria Victoria; Larocca, Alessandra; Ramasamy, Karthik; Kaiser, Martin; Cook, Gordon; Weisel, Katja C.; Costello, Caitlin L.; Elliott, Jennifer; Palumbo, Antonio; Usmani, Saad Z. | artículo de revisión |
| closedAccess |  | 2014 | New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Ocio, Enrique M. CSIC ORCID ; Richardson, Paul G.; Rajkumar, S. Vincent; Palumbo, Antonio; Mateos, Maria Victoria; Orlowski, R. Z.; Kumar, Sumit; Dimopoulos, Meletios A.; Merlini, Giampolo; Lahuerta, Juan José; Lonial, Sagar; Moreau, Philippe; Ludwig, Heinz; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2011 | Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: Consensus statement | Palumbo, Antonio; Delforge, Michel; Ludwig, Heinz; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2019 | Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial | Dimopoulos, Meletios A.; Gay, Francesca; Schjesvold, Fredrik; Beksac, Meral; Hajek, Roman; Weisel, Katja C.; Goldschmidt, Hartmut; Maisnar, Vladimir; Moreau, Philippe; Ki Min, Chang; Pluta, Agnieszka; Chng, Wee-Joo; Kaiser, Martin; Zweegman, Sonja; Mateos, Maria Victoria; Spencer, Andrew; Iida, Shinsuke; Morgan, Gareth J.; Suryanarayan, Kaveri; Teng, Zhaoyang; Skacel, Tomas; Palumbo, Antonio; Dash, Ajeeta B.; Gupta, Neeraj; Labotka, Richard; Rajkumar, S. Vincent | artículo |
| openAccess |  | 2013 | Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma | San Miguel, Jesús F. CSIC ORCID; Dimopoulos, Meletios A.; Palumbo, Antonio; Delforge, Michel; Mateos, Maria Victoria; Richardson, Paul G. | artículo |
| closedAccess |  | 2011 | Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN) | Palumbo, Antonio; Bladé, Joan; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2013 | Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group | Fernández de Larrea, Carlos; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio; Dimopoulos, Meletios A.; Chanan-Khan, Asher A.; Moreau, Philippe; Merlini, Giampolo; Lahuerta, Juan José; Bladé, Joan; Orlowski, R. Z. | artículo |
| closedAccess |  | 2013 | Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial | San Miguel, Jesús F. CSIC ORCID; Martínez-López, Joaquín; Palumbo, Antonio; Dimopoulos, Meletios A. | artículo |
| closedAccess |  | 2011 | Practical management of adverse events in multiple myeloma: Can therapy be attenuated in older patients? | Palumbo, Antonio; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
